CareGlance startup deeptech specializzata nello sviluppo e nella commercializzazione di sensori 3D a infrarossi basati su tecnologia OCT (optical coherence tomography), rende noto di avere chiuso un round seed da 3,5 milioni di euro.
The transaction is led by CDP Venture Capital, through the Rilancio Fund, with the participation of Eureka Venture, via the Eureka! Fund and the parallel fund dedicated to Puglia, alongside LIFTT and a group of business angels.
The funding will enable CareGlance to accelerate the commercialisation of its proprietary technology, boost product development activities and strengthen its presence across the country. In particular, the plan involves expanding the new operational headquarters in Puglia, which is strategic for software development and the consolidation of engineering expertise.
CareGlance develops and markets ultra-high-precision 3D infrared sensors, designed for advanced industrial applications where artificial intelligence needs eyes to see and hands to act. The company’s technology enables real-time monitoring of complex industrial processes, including laser welding, additive manufacturing and precision machining, setting new standards for automation, quality and reliability in Industry 4.0 and 5.0 contexts. In particular, the OCT solutions used by CareGlance are finding new applications for ‘non-destructive quality control’ across various sectors, including semiconductor inspection, multilayer coating inspection, composite analysis, battery inspection and the verification of microstructures produced via additive manufacturing.
Thanks in part to a close collaborative relationship with the Politecnico di Milano, the company has a solid portfolio of patents, comprising both licences granted by third parties and its own patents. In particular, CareGlance holds three patent families, consisting of patents already granted in the European Union and currently under examination in the United States.
“CareGlance addresses a real need within advanced industry: equipping automated systems with vision capabilities that match the complexity of the processes they are required to manage. Applying optical technology of this precision to fields such as additive manufacturing or laser welding enables monitoring and control to be taken to levels of accuracy that were previously unattainable.” “As CDP Venture Capital, we are particularly pleased to support a solution that lies at the heart of the Industry 4.0 and 5.0 transformation, in a market where demand for advanced and AI-enabled automation is set to grow significantly,” said Caterina Siclari, head of the CDP Venture Capital Relaunch Fund, in a statement.
“Eureka Venture!’s investment in CareGlance,” says Massimo Gentili, a partner at Eureka Venture, “meets the need to position its investment portfolio within the strategic sector of new manufacturing technologies. “In particular, the development of CareGlance’s proprietary technologies, specifically those relating to OCT (Optical Coherence Tomography), will provide manufacturers of laser welding equipment with a real-time control system for welding processes. This will improve production yields and consequently reduce the cost of the final product, addressing emerging needs such as, for example, those relating to the reduction of costs for electric traction batteries.”
“For LIFTT, this transaction represents a further step in the company’s long-term support strategy, which was already set in motion by previous investments,” adds Pierluigi Freni, project manager at LIFTT. “With this new investment, we are continuing to support a project in which we have believed since its earliest stages.” “CareGlance is developing a key technology for the evolution of industrial automation, taking OCT beyond its traditional scope and making it an enabling tool for increasingly intelligent production processes. The team’s ability to translate cutting-edge research into concrete industrial solutions is exactly what we at LIFTT are looking for in our approach to technology transfer.”
“With the support of investors who believe in our company, we are building a team where technological excellence is combined with a deep sense of responsibility and collaboration towards CareGlance’s goals. Our model is based on shared values and a passion for innovation. “Our aim is to revolutionise smart process control by equipping artificial intelligence with far more effective ‘eyes’ to understand what is actually happening within industrial processes, transforming data into actionable insights,” says Maria Chiara Ubaldi, CEO and founder of CareGlance (pictured).
ALL RIGHTS RESERVED ©